Innate cytokine responses that regulate autoimmunity
Innate cytokine responses that regulate autoimmunity
批准号:
7768461
负责人:
HARVEY CANTOR
金额:
$36.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2013-01-31
关键词:
AccountingAntigen PresentationAntigensAutoantigensAutoimmune ResponsesAutoimmunityBindingBiological ProcessCellsComplexCross PresentationDendritic CellsDevelopmentDiseaseEndosomesExonsExperimental Autoimmune EncephalomyelitisFibronectinsFundingGene ExpressionGenerationsGenesGeneticGrantIRAK1 geneImmune responseIn VitroInfectionInterferon-alphaInvestigationKnock-in MouseLeadMediatingMicrogliaModelingMolecularMultiple SclerosisMusMutant Strains MiceMutationOsteogenesisPathway interactionsPeptidesPhosphorylationPhysiologicalPopulationProductionProtein IsoformsProteinsQa-1 AntigenRNAResearchRoleSignal PathwaySignal TransductionSiteSpecific qualifier valueT-LymphocyteTestingTherapeutic EffectTranslationsUp-RegulationVascularizationbasecell typecytokineinsightinterferon alpha receptorinterferon alpha-beta receptormannose receptormutantnovel therapeutic interventionosteopontinpreventpublic health relevancereceptorresearch studyresponseselective expressionuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Progress in the research funded by this grant has led to the discovery that the Osteopontin gene specifies two distinct isoforms through differential translation of a single Opn RNA species: a cytokine in T cells and a critical intracellular protein expressed in dendritic cells. We have shown that Opn expression in plasmacytoid dendritic cells is essential for production of this cell's signature cytokine- interferon alpha. We have recently discovered that robust Th17 responses depend on the ability of a newly-defined intracellular Opn isoform- Opn-i - to inhibit secretion of IL-27 by DC. We have also defined an Opn-i-dependent interaction that prevents efficient development of Th17 responses. Interferon alpha/beta receptor (IFNAR)-dependent inhibition of Opn-i expression releases the brakes on IL-27 secretion and inhibits the Th17 response to self-peptides. Definition of the impact of this IFNAR:Opn-i axis on the Th1 and Th17 response has provided new insight into the basis for the therapeutic effects of IFN-I in Multiple Sclerosis and other Th17 diseases, as well as a rationale for new therapeutic approaches that engage this IFNAR:Opn-i pathway. We propose experiments (1) to define the genetic mechanism resulting in generation of Opn-i and Opn-s expression in DC and T cells; (2) to define the interaction between Opn-i and the MyD88 signaling module in plasmacytoid DC leading to IFN1 expression and enhanced Th1 development; (3) to analyze Opn-dependent interactions in conventional DC that regulate antigen presentation and Th17 development and (4) to generate mice that selectively express distinct Opn isoforms so that we may determine the contribution of Opn isoforms to the immune response to foreign and self antigens in the context of Experimental Autoimmune Encephalomyelitis (EAE mu model of MS. PUBLIC HEALTH RELEVANCE: The Osteopontin (Opn) gene is important in diverse biological processes, including immune responses, vascularization and bone formation, through its interaction with different cell types. Our recent discovery of the contribution of distinct secreted and intracellular isoforms of Opn to the generation of Th17 and Th1 subsets fills an important gap in understanding the genesis of these subsets in normal and autoimmune responses. We will generate mutant mice that express the intracellular or secreted Opn isoform for analysis of the contribution of each to protection again infection and in a murine model of Multiple Sclerosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunologic mechanisms that prevent autoimmunity
-
批准号:10265652
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2020
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6374616
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Regulation of the follicular T-cell response to autoimmunity
-
批准号:10066305
-
项目类别:
-
资助金额:$42.95万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6511531
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Innate cytokine responses that regulate autoimmunity
-
批准号:7650695
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6632442
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6196857
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Regulation of the follicular T-cell response to autoimmunity
-
批准号:9199455
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Innate cytokine responses that regulate autoimmunity
-
批准号:8212189
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6721340
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Innate cytokine responses that regulate autoimmunity
-
批准号:8016571
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
T CELL RECEPTOR COUPLED SIGNALING AND APOPTOSIS
-
批准号:6099898
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:HARVEY CANTOR
-
依托单位:
T CELL RECEPTOR COUPLED SIGNALING AND APOPTOSIS
-
批准号:6235317
-
项目类别:
-
资助金额:$20.03万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY
-
批准号:7123850
-
项目类别:
-
资助金额:$24.18万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY
-
批准号:2895490
-
项目类别:
-
资助金额:$14.97万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY
-
批准号:6771907
-
项目类别:
-
资助金额:$26.81万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
Postdoctoral Training Program in Cancer Immunology
-
批准号:7504248
-
项目类别:
-
资助金额:$19.63万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY
-
批准号:6376232
-
项目类别:
-
资助金额:$21.02万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
Postdoctoral Training Program in Cancer Immunology
-
批准号:8288582
-
项目类别:
-
资助金额:$20.19万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
Postdoctoral Training Program in Cancer Immunology
-
批准号:8103238
-
项目类别:
-
资助金额:$28.89万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
海外基金